SCHEMBL5198612

SCHEMBL5198612

CNNC(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.54
GRM6 O15303 1/20 0.54
GRIN2D O15399 1/20 0.54
GRIN3B O60391 1/20 0.54
GSR P00390 1/20 0.54
CYP1A2 P05177 1/20 0.54
GRIK1 P39086 1/20 0.54
GRM5 P41594 1/20 0.54
GRIA1 P42261 1/20 0.54
GRIA2 P42262 1/20 0.54
GRIA3 P42263 1/20 0.54
SLC1A3 P43003 1/20 0.54
SLC1A2 P43004 1/20 0.54
SLC1A1 P43005 1/20 0.54
GRIA4 P48058 1/20 0.54
GRIN1 Q05586 1/20 0.54
GRIN2A Q12879 1/20 0.54
GRIK2 Q13002 1/20 0.54
GRIK3 Q13003 1/20 0.54
GRIN2B Q13224 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL358758 0.83 GSR (0.58) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL8138 0.83 GSR (0.58) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL154380 0.83 GSR (0.58) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL31562940 0.79 GSR (0.62) GRM8GRM6GRIN2DGRIN3BGSR
Phosphoric Acid SCHEMBL8519189 0.77 GRM8 (0.50) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL8587639 0.77 PMP22 (0.52) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL11215138 0.77 GSR (0.60) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL10135850 0.77 GSR (0.60) GRM8GRM6GRIN2DGRIN3BGSR
Glutamine Hydroxamate SCHEMBL4321249 0.77 GSR (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Glutamine Hydroxamate SCHEMBL7645305 0.77 GSR (0.67) GRM8GRM6GRIN2DGRIN3BGSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017032798-A1 NOVEL INSULIN DERIVATIVES AND THE MEDICAL USES HEREOF NOVO NORDISK A/S (DK) 2017-03-02 WO disclosed
EP-1752143-A1 Novel uses for drugs targeting glutamine synthetase NewThera (FR) 2007-02-14 EP disclosed